Whole-brain radiotherapy (WBRT) and high-dose methylprednisolone (HDMP) for elderly patients with primary central nervous system lymphoma (PCNSL): Results of North Central Cancer Treatment Group (NCCTG) 96-72-51

被引：0
|
作者：
Laack, N
Ballman, KV
Brown, PB
O'Neill, BP
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Mayo Clin, Rochester, MN USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2004年 / 60卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1007
引用
收藏
页码：S260 / S261
页数：2
相关论文
共 50 条
  • [1] Toxicity of whole-brain radiotherapy (WBRT) and high-dose methylprednisolone (HDMP) for elderly patients (70 years of age and older) with primary central nervous system lymphoma (PCNSL): Results of north central cancer treatment group (NCCTG) 967251
    Laack, NN
    Ballman, KV
    Brown, PD
    O'Neill, BP
    NEURO-ONCOLOGY, 2004, 6 (04) : 361 - 361
  • [2] Whole-brain radiotherapy and high-dose methylprednisolone for elderly patients with primary central nervous system lymphoma: Results of North Central Cancer Treatment Group (NCCTG) 96-73-51
    Laack, Nadia N.
    Ballman, Karla V.
    Brown, Paul B.
    O'Neill, Brian Patrick
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 65 (05): : 1429 - 1439
  • [3] Salvage whole brain radiotherapy (WBRT) for patients with recurrent primary central nervous system lymphoma (PCNSL)
    Hottinger, AF
    DeAngelis, L
    Yahalom, J
    Abrey, L
    NEUROLOGY, 2006, 66 (05) : A337 - A337
  • [4] Combined treatment with high-dose methotrexate and whole brain radiation improves survival in primary central nervous system lymphoma (PCNSL)
    Abdelsalam, M. A.
    Hussainy, G.
    Akhtar, S.
    Maghfoor, I.
    Elweshi, A.
    Khafaga, Y.
    Alhuseini, H.
    Rahal, M.
    Alshabana, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [5] High-dose methotrexate, high-dose cytarabine and temozolomide for the treatment of primary central nervous system lymphoma (PCNSL)
    Maher Salamoon
    Taisir Hussein
    Mazen Kenj
    Marrouan Bachour
    Medical Oncology, 2013, 30
  • [6] High-dose methotrexate, high-dose cytarabine and temozolomide for the treatment of primary central nervous system lymphoma (PCNSL)
    Salamoon, Maher
    Hussein, Taisir
    Kenj, Mazen
    Bachour, Marrouan
    MEDICAL ONCOLOGY, 2013, 30 (04)
  • [7] Prevention of recurrence and prolonged survival in primary central nervous system lymphoma (PCNSL) patients treated with adjuvant high-dose methylprednisolone
    O'Neill, BP
    Habermann, TM
    Witzig, TE
    Rodriguez, M
    MEDICAL ONCOLOGY, 1999, 16 (03) : 211 - 215
  • [8] Prevention of recurrence and prolonged survival in primary central nervous system lymphoma (PCNSL) patients treated with adjuvant high-dose methylprednisolone
    BP O’Neill
    TM Habermann
    TE Witzig
    M Rodriguez
    Medical Oncology, 1999, 16 : 211 - 215
  • [9] Reduced-dose whole-brain radiotherapy with tumor bed boost after upfront high-dose methotrexate for primary central nervous system lymphoma
    Lee, Tae Hoon
    Lee, Joo Ho
    Chang, Ji Hyun
    Ye, Sung-Joon
    Kim, Tae Min
    Park, Chul-Kee
    Kim, Il Han
    Kim, Byoung Hyuck
    Wee, Chan Woo
    RADIATION ONCOLOGY JOURNAL, 2020, 38 (01): : 35 - 43
  • [10] High-dose methotrexate (HD-MTX) neoadjuvant chemotherapy for primary central nervous system lymphoma (PCNSL) in elderly patients
    Zhu, J.
    NEURO-ONCOLOGY, 2006, 8 (04) : 455 - 455
12345